Kelsey L Corrigan, Rebecca Paulus, Ann H Klopp, Lari B Wenzel, Anamaria R Yeung, J Spencer Thompson, Desiree E Doncals, Vijayananda Kundapur, Nancy H Wiggers, Dasarahally S Mohan, Sharad A Ghamande, Shannon N Westin, Kara L Schnarr, Michael L Haas, David K Gaffney, Steven E Waggoner, Pamela J Vanderwall, Noha T Jastaniyah, Stephanie L Pugh, Lisa A Kachnic
{"title":"Patient-Reported Outcomes During Pelvic Radiation Therapy: A Secondary Analysis on Sexual Function From NRG-RTOG 1203.","authors":"Kelsey L Corrigan, Rebecca Paulus, Ann H Klopp, Lari B Wenzel, Anamaria R Yeung, J Spencer Thompson, Desiree E Doncals, Vijayananda Kundapur, Nancy H Wiggers, Dasarahally S Mohan, Sharad A Ghamande, Shannon N Westin, Kara L Schnarr, Michael L Haas, David K Gaffney, Steven E Waggoner, Pamela J Vanderwall, Noha T Jastaniyah, Stephanie L Pugh, Lisa A Kachnic","doi":"10.1200/OA-24-00088","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>NRG-RTOG 1203 reported that intensity-modulated radiation therapy (IMRT) reduced patient-reported GI toxicities in patients with cervical/endometrial cancer receiving postoperative RT, compared with 3-dimensional conformal radiation therapy (3DRT). We conducted a secondary analysis of patient-reported sexual function (PR-SF) among treatment groups to identify factors associated with sexual dysfunction.</p><p><strong>Methods and materials: </strong>Patients on NRG-RTOG 1203 were randomly assigned to 3DRT versus IMRT and completed Patient-Reported Outcomes (PRO)-Common Terminology Criteria for Adverse Events (CTCAE) and FACT-Cx surveys at baseline, week 5 of RT, and at 4-6 weeks, 1 year, and 3 years after RT. Patient responses to FACT-Cx sexual function questions were analyzed. The between-arm frequency and severity of responses and their comparison with PRO-CTCAE GI toxicity were tested using chi-square tests. A repeated-measures logistic regression model was used to determine the impact of clinical and treatment factors on PR-SF.</p><p><strong>Results: </strong>Two hundred thirty-six patients completed PR-SF questions; 125 (53%) received 3DRT and 111 (47%) IMRT. There were no significant differences in PR-SF between groups (<i>P</i> > .05). After RT, responses to \"I am afraid to have sex\" and \"I am interested in sex\" significantly improved over time (<i>P</i> = .007 and <i>P</i> = .03, respectively). At 1 year after RT, women with interference from abdominal pain were more bothered by odor from the vagina versus women with no interference of abdominal pain (5% <i>v</i> 0%, <i>P</i> = .006). Additionally, at 1 year after RT, women with no severity of abdominal pain or no interference from abdominal pain liked their body appearance more versus women with at least some abdominal pain or some interference from abdominal pain (34% <i>v</i> 13%, <i>P</i> = .003 and 32% <i>v</i> 6%, <i>P</i> = .001, respectively).</p><p><strong>Conclusion: </strong>PR-SF was similar between treatment groups. After RT, fear of sex declined and interest in sex improved over time. Women with GI toxicity after RT completion are at risk for worse sexual function.</p>","PeriodicalId":520350,"journal":{"name":"JCO oncology advances","volume":"2 1","pages":"e2400088"},"PeriodicalIF":0.0000,"publicationDate":"2025-05-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12071503/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"JCO oncology advances","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1200/OA-24-00088","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Purpose: NRG-RTOG 1203 reported that intensity-modulated radiation therapy (IMRT) reduced patient-reported GI toxicities in patients with cervical/endometrial cancer receiving postoperative RT, compared with 3-dimensional conformal radiation therapy (3DRT). We conducted a secondary analysis of patient-reported sexual function (PR-SF) among treatment groups to identify factors associated with sexual dysfunction.
Methods and materials: Patients on NRG-RTOG 1203 were randomly assigned to 3DRT versus IMRT and completed Patient-Reported Outcomes (PRO)-Common Terminology Criteria for Adverse Events (CTCAE) and FACT-Cx surveys at baseline, week 5 of RT, and at 4-6 weeks, 1 year, and 3 years after RT. Patient responses to FACT-Cx sexual function questions were analyzed. The between-arm frequency and severity of responses and their comparison with PRO-CTCAE GI toxicity were tested using chi-square tests. A repeated-measures logistic regression model was used to determine the impact of clinical and treatment factors on PR-SF.
Results: Two hundred thirty-six patients completed PR-SF questions; 125 (53%) received 3DRT and 111 (47%) IMRT. There were no significant differences in PR-SF between groups (P > .05). After RT, responses to "I am afraid to have sex" and "I am interested in sex" significantly improved over time (P = .007 and P = .03, respectively). At 1 year after RT, women with interference from abdominal pain were more bothered by odor from the vagina versus women with no interference of abdominal pain (5% v 0%, P = .006). Additionally, at 1 year after RT, women with no severity of abdominal pain or no interference from abdominal pain liked their body appearance more versus women with at least some abdominal pain or some interference from abdominal pain (34% v 13%, P = .003 and 32% v 6%, P = .001, respectively).
Conclusion: PR-SF was similar between treatment groups. After RT, fear of sex declined and interest in sex improved over time. Women with GI toxicity after RT completion are at risk for worse sexual function.
目的:NRG-RTOG 1203报道,与三维适形放射治疗(3DRT)相比,调强放射治疗(IMRT)降低了宫颈癌/子宫内膜癌术后接受放疗的患者报告的胃肠道毒性。我们对治疗组患者报告的性功能(PR-SF)进行了二次分析,以确定与性功能障碍相关的因素。方法和材料:接受NRG-RTOG 1203治疗的患者被随机分配到3DRT和IMRT组,并在基线、放疗第5周、放疗后4-6周、1年和3年完成患者报告结果(PRO)-不良事件通用术语标准(CTCAE)和FACT-Cx调查。分析患者对FACT-Cx性功能问题的反应。采用卡方检验检验臂间反应频率和严重程度及其与PRO-CTCAE GI毒性的比较。采用重复测量logistic回归模型确定临床和治疗因素对PR-SF的影响。结果:236例患者完成了PR-SF问题;3DRT 125例(53%),IMRT 111例(47%)。PR-SF组间比较差异无统计学意义(P < 0.05)。在RT之后,“我害怕做爱”和“我对性感兴趣”的回答随着时间的推移显著改善(P = 0.007和P = 0.03)。在放疗后1年,有腹痛干扰的女性比没有腹痛干扰的女性更容易受到阴道气味的困扰(5% vs 0%, P = 0.006)。此外,在放疗后1年,没有严重腹痛或没有腹痛干扰的女性比至少有一些腹痛或腹痛干扰的女性更喜欢自己的身体外观(分别为34% vs 13%, P = 0.003和32% vs 6%, P = 0.001)。结论:两组间PR-SF相似。接受RT治疗后,对性的恐惧减少,对性的兴趣随着时间的推移而提高。在放射治疗完成后出现胃肠道毒性的女性存在性功能恶化的风险。